ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 11.282
EU - Europa 5.310
AS - Asia 4.344
SA - Sud America 1.097
AF - Africa 208
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.246
Nazione #
US - Stati Uniti d'America 11.128
DE - Germania 2.081
SG - Singapore 1.905
CN - Cina 1.008
BR - Brasile 942
RU - Federazione Russa 905
HK - Hong Kong 683
SE - Svezia 634
GB - Regno Unito 518
IT - Italia 429
VN - Vietnam 239
FI - Finlandia 213
UA - Ucraina 133
CI - Costa d'Avorio 112
FR - Francia 109
IN - India 106
ID - Indonesia 90
CA - Canada 77
BD - Bangladesh 73
AR - Argentina 62
PL - Polonia 49
MX - Messico 48
BE - Belgio 42
JP - Giappone 41
ZA - Sudafrica 40
IQ - Iraq 36
IE - Irlanda 31
ES - Italia 30
TR - Turchia 28
AT - Austria 26
NL - Olanda 23
CZ - Repubblica Ceca 22
EC - Ecuador 19
VE - Venezuela 19
LT - Lituania 16
CO - Colombia 12
JO - Giordania 12
MA - Marocco 12
CL - Cile 11
PE - Perù 11
PK - Pakistan 11
PY - Paraguay 11
NP - Nepal 10
RO - Romania 10
TN - Tunisia 10
IR - Iran 9
KE - Kenya 9
KZ - Kazakistan 9
SA - Arabia Saudita 9
ET - Etiopia 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
TH - Thailandia 7
UZ - Uzbekistan 7
BO - Bolivia 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
DO - Repubblica Dominicana 4
LB - Libano 4
RS - Serbia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
GE - Georgia 3
HU - Ungheria 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
YE - Yemen 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
Totale 22.226
Città #
Fairfield 1.541
Ashburn 1.234
Singapore 964
Woodbridge 896
Chandler 835
Houston 721
Hong Kong 678
Seattle 670
Cambridge 529
Nyköping 517
Wilmington 460
Beijing 373
New York 358
Ann Arbor 351
Jacksonville 307
Los Angeles 222
Lawrence 181
Roxbury 175
Bari 138
Munich 134
Dallas 123
Nanjing 117
Abidjan 111
Des Moines 104
Brooklyn 101
Princeton 83
São Paulo 79
Jakarta 74
Boardman 69
Helsinki 69
Ho Chi Minh City 67
Inglewood 63
San Diego 61
Santa Clara 59
London 56
Buffalo 55
Falkenstein 54
Moscow 54
Dong Ket 50
Brussels 42
Hanoi 39
Paris 39
Redwood City 38
Warsaw 38
Nanchang 37
Turku 37
Nuremberg 35
Tokyo 35
Chicago 33
Montreal 31
Denver 30
Johannesburg 30
Rio de Janeiro 30
Shenyang 30
Dublin 29
Frankfurt am Main 28
Columbus 27
Jiaxing 27
Belo Horizonte 26
Changsha 26
Dearborn 26
Milan 26
Tianjin 26
The Dalles 25
Hebei 24
Guangzhou 23
Atlanta 22
Council Bluffs 22
Pune 22
Rome 22
Chennai 21
Marseille 21
San Francisco 21
Dhaka 20
Mexico City 18
Shanghai 18
Brasília 17
Poplar 17
Boston 16
Falls Church 16
Salvador 16
Stockholm 16
Phoenix 15
Toronto 15
Portsmouth 14
Brno 13
Curitiba 13
Porto Alegre 13
Salt Lake City 13
Wuhan 13
Baghdad 12
Campinas 12
Mumbai 12
Ankara 11
Manchester 11
Amsterdam 10
Düsseldorf 10
Ningbo 10
Fortaleza 9
Jinan 9
Totale 14.090
Nome #
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 225
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 221
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 206
Monosomal karyotype in myeloid neoplasias: a literature review 197
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 195
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 191
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 187
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 186
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 185
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 181
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 179
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 177
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 175
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 175
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 172
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 172
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 169
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 167
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 166
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 165
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 164
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 163
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 163
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 155
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 154
Decreased TET2 gene expression during chronic myeloid leukemia progression 153
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 152
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 151
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 151
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 151
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 151
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 150
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 150
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 150
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 149
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 149
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 148
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 147
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 147
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 146
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 144
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 144
Non-treatment-related chronic myeloid leukemia as a second malignancy 143
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 143
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 142
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 142
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 141
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 139
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 139
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 138
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 138
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 137
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 137
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 136
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 135
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 135
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 134
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 133
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 132
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 130
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 130
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 130
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 130
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 130
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 129
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 128
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 128
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 127
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 127
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 126
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 126
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 125
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 124
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 124
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 124
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 123
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 123
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 123
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 123
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 123
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 121
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 121
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial 120
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 120
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 120
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 120
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 119
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 118
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 118
Characterization of der(9) deletions in CML patients 116
Extramedullary disease in acute promyelocytic leukemia: two-in-one disease. 116
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 116
null 115
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 115
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9) 114
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia 113
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 111
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 111
A rare case of IgM-Multiple Myeloma 109
Upregulation of MEL1 and FLJ42875 genes by position effect resulting from a t(1;2)(p36;p21) occurring during evolution of chronic myelomonocytic leukemia 108
Totale 14.341
Categoria #
all - tutte 99.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.287 0 0 0 0 0 207 114 295 125 247 140 159
2021/20221.410 127 137 19 34 65 132 70 58 122 124 223 299
2022/20232.244 308 307 157 153 228 315 38 270 347 11 49 61
2023/20241.070 79 138 56 58 106 406 24 43 5 29 17 109
2024/20254.090 152 68 263 178 156 339 509 352 185 251 560 1.077
2025/20264.502 1.177 402 613 1.027 1.117 166 0 0 0 0 0 0
Totale 22.969